Form 8-K - Current report:
SEC Accession No. 0001829126-25-009750
Filing Date
2025-12-05
Accepted
2025-12-05 16:17:15
Documents
17
Period of Report
2025-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opgeninc_8k.htm   iXBRL 8-K 31155
2 EXHIBIT 10.1 opgeninc_ex10-1.htm EX-10.1 65510
3 EXHIBIT 10.2 opgeninc_ex10-2.htm EX-10.2 22881
4 GRAPHIC ex10-1_001.jpg GRAPHIC 27983
5 GRAPHIC ex10-2_001.jpg GRAPHIC 27983
6 GRAPHIC ex10-2_002.jpg GRAPHIC 1648
  Complete submission text file 0001829126-25-009750.txt   374798

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE opgn-20251201.xsd EX-101.SCH 2990
8 XBRL LABEL FILE opgn-20251201_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE opgn-20251201_pre.xml EX-101.PRE 22342
19 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_8k_htm.xml XML 3543
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 251553189
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)